Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Novo Nordisk NVO

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes... see more

Current News (NYSE:NVO)

Novo Nordisk's CagriSema was associated with significant reduction in blood pressure and showed anti-inflammatory effects while reducing the proportion of patients at risk of developing heart disease over time in new analyses at ObesityWeek®

PR Newswire November 6, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 30, 2025 in Novo Nordisk A/S Lawsuit - NVO

GlobeNewswire October 1, 2025

Class Action Filed Against Novo Nordisk A/S (NVO) Seeking Recovery for Investors - Contact Levi & Korsinsky

PR Newswire October 1, 2025

Lost Money on Novo Nordisk A/S (NVO)? Urged to Join Class Action Before September 30, 2025 - Contact Levi & Korsinsky

ACCESS Newswire September 30, 2025

NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit with the Schall Law Firm

PR Newswire September 30, 2025

Time to SueWallSt? Levi & Korsinsky Files Lawsuit Over Novo Nordisk A/S Stock Losses

ACCESS Newswire September 30, 2025

Levi & Korsinsky Urges Novo (NVO) Shareholders to Act Before Lead Plaintiff Deadline September 30, 2025

ACCESS Newswire September 30, 2025

NVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire September 30, 2025

DEADLINE ALERT for NVO and LINE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

GlobeNewswire September 30, 2025

Opinion & Analysis (NYSE:NVO)

Top First Quarter European ETFs

Benzinga.com  March 31, 2015

A Look At 4 ETFs From The 4 'Least Corrupt' Countries

Benzinga.com  December 4, 2014

Bullboard Posts (NYSE:NVO)

Novo Nordisk’s Payout Potential in 2025

The NVO dividend yield currently stands around 2.24%, based on an annual payout of $1.23 per share and a share price near $55. Novo...
EvansWilson - September 18, 2025

Novo Nordisk: Big Pharma’s Next Crown Jewel?

Potential Medicare and Medicaid coverage expansion for anti-obesity drugs could be a game-changer. I'm bullish on NVO's long-term...
Trader19Swift - December 2, 2024

Please take a look

https://www.change.org/p/fda-and-ema-improving-the-public-health?recruiter=1170861947&recruited_by_id=6f0edee0-47cf-11eb-a646...
scarlet1967 - May 26, 2021

Bonvoyage12.....Lying Pumper

Ignore this clown as he posts lies trying to mislead investors about the actual state of the company...he also posts this same BS on...
Mil_Man54 - December 26, 2020

wits 1.0 not everywhere either

it is in 7 distinct places, with about 5-15 g/t averages for hundreds of square km's. A dry hole for us is a dry hole. Doesn't...
jonggua - October 11, 2017

UV Flu technologies (UVFT) up over 45% in the last

UV Flu Technologies (OTC BB: UVFT) stock is up over 45% in the last week, and is still severely undervalued at these levels! UVFT's...
jbjohnbedford - October 26, 2010